You are signed out
Join Innoget to connect with Eluemuno Blyden and thousands
of innovation-driven professionals and organizations
Eluemuno Blyden
Founder/CEO at Avril Biopharma,. Inc.
United States · San Francisco/CaliforniaJoined October 2020
Describe it (summary)
Avril Biopharma is a future-of-medicine company developing biopharmaceutical products using:
-- Customized interventions for rare diseases and gene therapy (anti-cancer vaccines; enzyme therapy, AAV viral vectors);
-- Rapid development and production scale-up or scale-down for vaccines, therapeutics, biosimilars & diagnostics.
Our goal is to enable a future of rapid, safe and affordable personalized medicine for all.
COVID-19: In an effort to contribute our technology and know-how to the fight against COVID19, we are interested in working with companies developing recombinant protein countermeasures for diagnostics, therapeutics or vaccine products. Please contact Dr. Blyden at the address provided or on LinkedIn.
Academic Studies (1)
Ph.D.
Cambridge University
January 1983 - January 1988
Plant Molecular Genetics
https://www.google.com/search?client=firefox-b-1-e&q=Eluemuno+blyden+blyden+PhD+cambridge
Research areas of interest (3)
- Biological Sciences
- Genetic Engineering / Molecular Biology
- Bioinformatics Market
Eluemuno Blyden didn't publish any Technology Call yet
Eluemuno Blyden didn't publish any Paper yet
Eluemuno Blyden didn't publish any Event yet
Eluemuno Blyden didn't publish any Job yet
Eluemuno Blyden didn't publish any New and Article yet
Eluemuno Blyden didn't publish any Education Resource yet
